FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/06/043470 [Registered on: 24/06/2022] Trial Registered Prospectively
Last Modified On: 23/06/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Other 
Public Title of Study   To study the effect of Nalbuphine in prolongation of duration of post-operative analgesia when it is added as an adjuvant to 0.5%Ropivacaine in ultrasound guided supraclavicular brachial plexus blocks 
Scientific Title of Study   The analgesic effect of Nalbuphine as an adjuvant to 0.5% Ropivacaine in Ultrasound Guided Supraclavicular Brachial Plexus Nerve Blocks : a prospective interventional study at SMS Hospital, Jaipur during 2021-2023.  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Chitra Singh 
Designation  Associate Professor  
Affiliation  SMS MEDICAL COLLEGE AND HOSPITAL, JAIPUR 
Address  Department of Anaesthesia, second floor, Dhanwantari Building, JAIPUR 302004 Rajasthan

Jaipur
RAJASTHAN
302004
India 
Phone  9166609479  
Fax    
Email  raghuvanshichitra@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Chitra Singh 
Designation  Associate Professor  
Affiliation  SMS MEDICAL COLLEGE AND HOSPITAL, JAIPUR 
Address  Department of Anaesthesia, second floor, Dhanwantari Building, JAIPUR 302004 Rajasthan

Jaipur
RAJASTHAN
302004
India 
Phone  9166609479  
Fax    
Email  raghuvanshichitra@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Mohit Mathur 
Designation  PG Student 
Affiliation  SMS MEDICAL COLLEGE, JAIPUR  
Address  Department of Anaesthesia, second floor, Dhanwantari Building, JAIPUR 302004 Rajasthan

Jaipur
RAJASTHAN
302004
India 
Phone  9799920020  
Fax    
Email  mohitzmathur@gmail.com  
 
Source of Monetary or Material Support  
Department of Anaesthesia, second floor, Dhanwantari Building, SMS MEDICAL COLLEGE , JAIPUR 302004 Rajasthan 
 
Primary Sponsor  
Name  Department of Anaesthesia  
Address  SMS MEDICAL COLLEGE, JAIPUR 302004 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr CHITRA SINGH  SMS MEDICAL COLLEGE AND HOSPITAL, JAIPUR   DEPARTMENT OF ANAESTHESIA, SECOND FLOOR, DHANVANTARI BUILDING, JAIPUR 302004 RAJASTHAN
Jaipur
RAJASTHAN 
9166609479

raghuvanshichitra@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SMS MEDICAL COLLEGE ETHICS COMMITTEE, JAIPUR  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: S52||Fracture of forearm,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  inj. Nalbuphine  Inj. Nalbuphine 10mg(1ml) as an adjuvant to 0.5% Ropivacaine(20ml) in USG guided supraclavicular brachial plexus nerve block . After drug intervention, observation of patient will be done till request of first rescue analgesia. 
Comparator Agent  USG guided supraclavicular brachial plexus nerve block.  0.5% Ropivacaine(20ml) and saline (1ml) in USG guided supraclavicular brachial plexus nerve block. After drug intervention, observation of patient will be done till request of first rescue analgesia. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1.participant of fracture forearm surgeries under USG guided supraclavicular block. 2. ASA physical status class 1and 2 . 3. patients willing to participate. 
 
ExclusionCriteria 
Details  1. Patients with a history of allergy or hypersensitivity to either local anaesthetics or opioid group of drugs. 2. Any contra indication to peripheral nerve block. 3.impaired ability to communicate. 4.patients with raised intracranial tension. 5.pregnancy. 6.patient with coagulation disorder. 7.local infection/swelling at the site of injection. 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Duration of post-operative analgesia according to NRS scale.(time of first request of rescue analgesia).  Every 30 minutes in first hour then every one hourly in next twelve hours. 
 
Secondary Outcome  
Outcome  TimePoints 
Mean duration of analgesia  In post-operative period 
Haemodynamic parameters  Intraoperative period 
Proportion of cases with complications  Post operative period 
Side-effects  If any 
 
Target Sample Size   Total Sample Size="64"
Sample Size from India="64" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   24/06/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   In this double blinded randomized controlled interventional study, we will compare the analgesic effect of nalbuphine as an adjuvant to 0.5% ropivacaine in ultrasound guided supraclavicular brachial plexus nerve blocks  with the analgesic effect of 0.5% ropivacaine alone in ultrasound guided supraclavicular brachial plexus nerve blocks . 
Close